Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Kathy Ireland Contributes $100,000 World Aids Day Gift To The Elizabeth Taylor AIDS Foundation Announces Level Brands Inc.
  • USA - English


News provided by

Level Brands

Dec 07, 2017, 13:15 ET

Share this article

Share toX

Share this article

Share toX

Kathy Ireland wearing vintage gifts from Elizabeth Taylor and honoring Dame Elizabeth's iconic AIDS ribbon and White Diamonds perfume. Photographed by Nikon ambassador Dixie Dixon.
Kathy Ireland wearing vintage gifts from Elizabeth Taylor and honoring Dame Elizabeth's iconic AIDS ribbon and White Diamonds perfume. Photographed by Nikon ambassador Dixie Dixon.

This funding is a clarion call to the fact that the battle to treat, provide care and to accelerate a cure for HIV/AIDS is far from over and that complacency is the chief obstacle to securing victory

Post this

(PRWEB) December 07, 2017 -- To call attention to the continuing urgency of the battle to address and conquer HIV/AIDS, Level Brands, Inc. has announced that its Chairman Emeritus and Chief Brand Strategist, Kathy Ireland--also chair of kathy ireland Worldwide (kiWW)--has made a 2017 World AIDS Day contribution of $100,000 to The Elizabeth Taylor AIDS Foundation (ETAF). "This funding is a clarion call to the fact that the battle to treat, provide care and to accelerate a cure for HIV/AIDS is far from over and that complacency is the chief obstacle to securing victory," was noted in a joint statement from Jon Carrasco and Stephen Roseberry, Global Creative Director and President, respectively, of Level Brands' companies EE1, I'M1, kathy ireland Health and Wellness as well as kiWW.

Kathy Ireland remarked that the gift "celebrates my dear late friend and mentor, Dame Elizabeth Taylor and her inspiring and unrelenting philanthropy through which she personally willed and powered the global war on HIV/AIDS. Elizabeth still holds those living with HIV/AIDS and those in danger of contracting AIDS under the shelter of her loving wings, assuring that every dollar of donation to ETAF goes directly to care and prevention. Her passionate activism to end HIV/AIDS reigns as one of her most notable and lasting legacies, a fight continued today through The Elizabeth Taylor AIDS Foundation. The organization's ability to give back relies on this great lady's gracious contributions during her lifetime, including arranging for the foundation to continue in perpetuity to have all operating costs paid for by her Trust. Much of Dame Elizabeth's on-going support derives from the sustaining popularity of her iconic White Diamonds perfume fragrance, the only diamonds that saved and continues to save lives."

Ms. Ireland, a world-renowned entrepreneur like her legendary mentor, emphasizes that "World AIDS Day is an important reminder of Elizabeth's demand that we achieve an AIDS free generation. Under Elizabeth's guidance, great strides were made, but the war has not been won. We have not made that happen yet, for the millennial generation, but we must make it happen for the children whose names we know, including: Ezra, Madilynn-Rose, Vivienne and those people we do not know. We constantly meet people of all ages committed to the compassionate dedication Elizabeth lived. That is the amazing legacy Elizabeth left for the world."

"Elizabeth Taylor's passionate activism to end HIV/AIDS and funding that effort, even beyond her passing, reigns as one the most notable and lasting legacies of all time," added Carrasco and Roseberry, each of whom were active participants in the great star's professional activities and philanthropies. "One of the greatest privileges of our entire lives was being in service to Elizabeth when she conceived the HIV/AIDS treatment innovation of bringing vans of pharmacology and medical professionals to people in need during Hurricane Katrina. Elizabeth had countless wonderful qualities. Patience, in the face of suffering, was not one of them. When Elizabeth felt our government could not respond quickly enough to the disaster of Katrina, she stepped in with her foundation, recruited medical teams and wrote personal checks to make an immediate difference. Elizabeth made the work of public health heroes, like Dr. Michael Gottlieb, Martin Delany, Dr. Margrit Carlson and Dr. Anthony Fauci of the NIAID, powerfully visible. The depth and commitment of Elizabeth Taylor to saving lives, through the scourge of HIV/AIDS, has yet to be told."

"The exemplary way in which the Elizabeth Taylor Trust supports the foundation through its Managing Director Joel Goldman and its Co-Trustees Barbara Berkowitz, Tim Mendelson and Quinn Tivey is an inspiration for everyone who is committed to philanthropy and who uses resources to continue making a difference even beyond their own mortality," notes Ireland. "When talking with Elizabeth about her HIV/AIDS work, she would occasionally say 'I hope I made a little difference.' In fact, Elizabeth made an extraordinary difference by co-founding amfAR and The Elizabeth Taylor AIDS Foundation as well as through her countless heroic deeds to support disenfranchised people who were fighting for their lives, battling bigotry and prejudice, which sadly still exists. There is no question that Elizabeth will always be known as the Joan of Arc of AIDS. At no time, did Elizabeth ever consider the personal dangers and financial costs. It is hard to realize that in the 1980s many people were unaware of what caused HIV/AIDS. Elizabeth was the first person with a global public platform, which she used strictly for good, to say 'We're fighting a disease, not people.' Elizabeth frequently visited patients in a private way. She held them, cared for them, and gave them the greatest human kindness, which is love. There have been many debates about Elizabeth's support of making drugs available to people in need from her home. It was illegal, it was dangerous and it was something she simply had to do. Today, sadly, because Elizabeth never needed or sought publicity, so much of her heroism is unknown, especially to this generation. Children born in this decade must know about this woman, who is so much more than the most celebrated actor in film. Elizabeth is a woman of faith, family and friendship. A great and loving mother and grandmother, she placed the needs of everyone in her life above her own. On Dec 1st, 2017, on World AIDS Day, we salute Elizabeth with this contribution and look forward to continuing it in the years ahead."

Blake Van Leer, Level Brands, http://www.levelbrands.com/, +1 (202) 525-8717, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.